Webinar Archives | PetDx®

2022, October 17 – Free CE Webinar

Title: Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing. Description: At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of “liquid biopsy” for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with recent clinical laboratory experience and case examples from real-world veterinary practices.

2022, October 11 – Free Vetcetera Webinar

Title: Is it cancer? Use of a blood-based test as an aid-in-diagnosis for cancer detection in dogs. Description: What do you do when a dog presents with an abdominal mass that you can’t access for FNA or biopsy? How about a case where cytology or histopathology is inconclusive, but you still suspect cancer? What about a situation where you recommend biopsy, but the owner objects because they feel it is too invasive? When a dog is suspected of having cancer, the workup can take many forms and a variety of testing modalities may be needed to arrive at a definitive or presumptive diagnosis. This session will review a novel tool in the clinician’s toolbox – liquid biopsy – a test that evaluates a blood sample for the presence of circulating tumor DNA which indicates the current presence of cancer in the body. This session will review the basic principles of liquid biopsy testing and how this technology may be useful as an aid-in-diagnosis. A series of illustrative case samples will be presented, demonstrating how liquid biopsy has been used in the evaluation of dogs with suspected cancer.

2022, September 20 – Free VetMedTeam Webinar

Title: Recent Advances in Veterinary Oncology: Updates Every General Practitioner Should Know. Description: During this webinar, Rachel Venable, DVM, MS, DACVIM (Oncology) will provide an overview of recent advances in oncology. The presentation discusses novel treatments and a new early cancer detection test. A review of the mechanism of action, study results, and uses of an oral treatment for canine lymphoma (Laverdia) along with an injectable treatment for canine mast cell tumor (Stelfonta) will be discussed. The presentation also provides a basic overview of cancer biology and introduces the fundamentals of blood-based “liquid biopsy” testing for canine cancer detection using next-generation sequencing of cell-free DNA (OncoK9). A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs is included.

2022, September 14 – Free CE Webinar

Title: Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing. Description: At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of liquid biopsy for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with recent clinical laboratory experience and case examples from real-world veterinary practices.

Tags:

2022, August 30 – Free CE Webinar

Title: Cancer in dogs: How and when is it detected and is there room for improvement? Description: Major veterinary medical organizations recognize the importance of early cancer detection in dogs. However, guidelines driven screening protocols for early cancer detection are lacking, and cancer is often detected at advanced stages. Diagnosis of canine cancer at earlier stages or substages, prior to the onset of clinical signs, has been proven to lead to better outcomes for many cancer types. This session will examine data from over 350 cancer diagnosed dogs to establish how the presenting complaint came to attention and led to a definitive diagnosis of cancer in these patients. Additionally, the session will review the typical age at which cancer is diagnosed in dogs from a cohort of over 3,000 cancer diagnosed patients. Using this data, an age to start cancer screening can be recommended, based on the breed or weight of an individual dog. The session will conclude with a discussion of how blood based liquid biopsy testing may offer a convenient, noninvasive screening tool to aid in the earlier identification of cancer in dogs.This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-921743).

2022, August 3 – Free CE Webinar

Title: Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing. Description: At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of liquid biopsy for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with recent clinical laboratory experience and case examples from real-world veterinary practices. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-909052).

2022, July 20 – Free VetMedTeam Webinar

Cancer in dogs: How and when is it detected and is there room for improvement?Major veterinary medical organizations recognize the importance of early cancer detection in dogs. However, guidelines-driven screening protocols for early cancer detection are lacking and cancer is often detected at advanced stages. This webinar will examine data from over 350 cancer-diagnosed dogs to establish how the presenting complaint came to attention and led to a definitive diagnosis of cancer in these patients.Additionally, the presentation will review the typical age at which cancer is diagnosed in dogs from a cohort of over 3,000 cancer-diagnosed patients. Using this data, an “age to start cancer screening” can be recommended, based on an individual dog’s breed or weight. The webinar will conclude with a discussion of how blood-based liquid biopsy testing may offer a convenient, non-invasive, screening tool to aid in the earlier identification of cancer in dogs. The presenter is Angela McCleary-Wheeler, DVM, PhD, DACVIM (Oncology).

2022, June 28 – Free Vetcetera Webinar

Title: Cancer detection in 2022: Can a blood test really find 30 different types of cancer in dogs? Description: The session sponsored by PetDx will review data from the CANcer Detection in Dogs study that validates PetDx’s “liquid biopsy” technology for cancer detection in dogs. Dr. Andi Flory will review the clinical applications of this innovative cell-free DNA-based technology and provide initial laboratory experience showing how this test is being used in veterinary practices across the country.

2022, June 7 – Free CE Webinar

Title: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Description: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

2022, July 6 – Free CE Webinar

Title: Detect 30 different types of canine cancer with a simple blood draw: Introducing liquid biopsy testing. Description: At its most fundamental level, cancer is caused by abnormalities in DNA. Advanced genomic sequencing technologies now allow for the identification of these abnormalities using a simple blood draw, opening the door to non-invasive cancer detection in dogs. This session will provide a basic overview of cancer biology and introduce the fundamentals of liquid biopsy for canine cancer detection using next-generation sequencing of cell-free DNA. A review of the peer-reviewed clinical validation study of this testing in over 1,000 dogs will be presented, along with recent clinical laboratory experience and case examples from real-world veterinary practices. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-909052).

2022, May 25 – Free Clinician’s Brief Webinar

New cutting-edge technology is helping general practitioners detect more than 30 types of cancer with a single blood draw. Join us in this webinar to see how you, your practice, and your patients could benefit from liquid biopsy testing.

Tags:

2022, May 4 – Free CE Webinar

Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

2022, Apr 26 – Free VetMedTeam Webinar

Webinar: Integrating Canine Liquid Biopsy Testing Into Your Practice. Did you know that there is now a blood test that can detect 30 different types of cancer in dogs? “Liquid biopsy” using next-generation sequencing offers veterinarians a new option for canine cancer testing using a simple blood draw.

Join Andi Flory, DVM, DACVIM (Oncology), to review the clinical validation of a next-generation sequencing-based liquid biopsy test in over 1,000 dogs. Strategies for incorporation of this novel technology into routine clinical practice will be provided and case studies will be presented that describe real-world applications of this testing. The session will also examine ways to explain this advanced genomic technology to pet parents and how to interpret test results in the context of each patient’s unique clinical presentation.

Tags:

2022, April 6 – Free DVM360 Webinar

The idea that a single blood test could detect 30 different types of cancer may have seemed far-fetched a few short years ago; however, “liquid biopsy” testing now offers veterinarians a non-invasive option for cancer detection using a simple blood draw. This session will provide an overview of how next-generation sequencing can be used to detect cancer-associated genomic alterations in the blood of dogs. The clinical validation data from over 1,000 dogs will be presented, along with a review of how test performance (sensitivity, specificity, positive and negative predictive values) can be interpreted and explained to help pet parents understand what a positive or negative liquid biopsy result really means for their dog. The session will conclude with a series of interesting case studies demonstrating the potential utility of this test as a screening tool for healthy dogs and as an aid-in-diagnosis for dogs suspected to have cancer.

Tags:

2022, April 19 – Free CE Webinar

Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

2022, March 15 – Free CE Webinar

Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

2022, Feb 24 – Free CE Webinar

Title: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

Tags:

2022, Jan 25 – Free CE Webinar

Title: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

Tags:

2021, Nov 30 – Free CE Webinar

Title: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

Tags:

2021, Nov 17 – VetMedTeam Webinar

Cancer Detection in Dogs – With Just a Blood Draw. Blood-based cancer detection, or ‘liquid biopsy’, is now available for both dogs and humans and provides veterinarians with an exciting new tool in cancer detection and characterization. This presentation will outline the fundamental scientific advances behind this technology, including cancer genomics and next-generation sequencing-based detection of circulating tumor DNA. Clinical uses in veterinary medicine will be discussed, with a specific focus on screening for early cancer detection and aid in diagnosis.

Tags:

2021, Dec 12 – VETgirl Webinar

Can a Blood Test Really Detect Cancer in Dogs? Yes, a blood test really can detect cancer! In this complimentary VETgirl – PetDx webinar, Dr. Andi Flory, DACVIM (Oncology) reviews how a blood test can detect cancer in dogs. The term “liquid biopsy” broadly refers to the sampling and analysis of analytes from biological fluids, including blood. Tune in to find out more about this cutting-edge diagnostic approach that can be added to your arsenal for the detection and characterization of cancer.

Tags:

2021, Nov 2 – DVM360 Webinar

Blood-Based Liquid Biopsy: A New Approach to Canine Cancer Detection. Has a client ever said to you, “Can you tell if my dog has cancer from the blood work”?

Tags:

2021, Oct 7 – Webinar with VIN

Veterinary Information Network – Webinar
Detecting Cancer in Dogs with Just a Blood Draw: An Introduction to Liquid Biopsy

2021, Oct 22 – Free CE Webinar

Title: Liquid biopsy for non-invasive multi-cancer detection and characterization in dogs. Synopsis: Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA-based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease. This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval (Tracking number 20-848616).

Tags:
Top